ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666571 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666571; 2) Community: the network communities that were significantly associated with the response to NSC 666571; 3) Molecule: the relationships between components within communities and NSC 666571; 4) MDR: the compounds that were significantly associated with the NSC 666571.

NSC Compound Enrichment Correlation
NSC 734977 Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate 0.0385067071027345 0.25440047
NSC 740602 Null 0.0385067071027345 0.32012299
NSC 701759 Null 0.0385203205529754 0.43533508
NSC 741078 Selumetinib 0.0385203205529754 0.011833079
NSC 129220 O2,2'-Cyclocytidine monoacetate 0.0385203205529756 0.1836008
NSC 163062 TRIPTOLIDE 0.0385203205529756 0.19510368
NSC 237538 2,4-Thiazolidinedione, 5-(3-phenyl-2-propenylidene)- 0.0385203205529756 0.29693881
NSC 368891 Null 0.0385203205529756 0.29930369
NSC 373355 Saframycin R 0.0385203205529756 0.25344825
NSC 48300 ANTINEOPLASTIC-48300 0.0385203205529756 0.37371176
Total:78  Current:63    [First] [Prev] [Next] [Last]